ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 5176

$2.15M Total Retail Price of All Prescriptions

Rank: 43 out of 5176

655 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 655 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 655 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 28,009 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
WARFARIN SODIUM 1,072 1,060 1 13
NEXIUM 915 850 2 16
METOPROLOL TARTRATE 796 776 3 6
SIMVASTATIN 792 737 4 1
CRESTOR 617 560 5 15
ENALAPRIL MALEATE 579 554 6 22
ATORVASTATIN CALCIUM 570 533 7 9
AMLODIPINE BESYLATE 563 524 8 2
LOSARTAN POTASSIUM 530 501 9 14
CARVEDILOL 525 473 10 24
TAMSULOSIN HCL 510 458 11 20
SYNTHROID 465 434 12 33
METOPROLOL SUCCINATE 459 443 13 11
ZOLPIDEM TARTRATE 406 403 14 17
OMEPRAZOLE 402 367 15 3
PLAVIX 398 384 16 29
DIOVAN HCT 378 362 17 39
DIOVAN 356 346 18 19
CLOPIDOGREL 354 338 19 26
LIPITOR 349 330 20 51
LOSARTAN-HYDROCHLOROTHIAZIDE 338 314 21 35
COUMADIN 323 311 22 112
FUROSEMIDE 308 305 23 8
LIDODERM 296 291 24 59
FELODIPINE ER 287 270 25 128
JANUVIA 284 259 26 25
ISOSORBIDE MONONITRATE ER 268 257 27 44
DONEPEZIL HCL 266 266 28 28
CLOTRIMAZOLE-BETAMETHASONE 265 259 29 94
POTASSIUM CHLORIDE 262 262 30 34
RANITIDINE HCL 260 256 31 36
GLIPIZIDE 256 240 32 63
ATENOLOL 248 247 33 12
LEVOTHYROXINE SODIUM 248 227 33 4
LACTULOSE 237 227 35 87
FINASTERIDE 232 232 36 69
METFORMIN HCL 222 194 37 7
LOVAZA 219 189 38 43
FAMOTIDINE 218 190 39 58
ALENDRONATE SODIUM 215 190 40 18
BENICAR HCT 213 204 41 110
LISINOPRIL 208 207 42 5
GLYBURIDE-METFORMIN HCL 194 170 R 43 76
DIGOXIN 187 172 44 56
HYDROCHLOROTHIAZIDE 175 162 45 10
VOLTAREN 175 160 45 97
HYDRALAZINE HCL 174 172 47 73
CYMBALTA 172 143 48 90
HYDROCODONE-ACETAMINOPHEN 171 168 S3 49 27
DILTIAZEM 24HR CD 166 166 50 119
BENICAR 160 158 51 100
SILVER SULFADIAZINE 158 153 52 207
TORSEMIDE 155 146 53 184
CELEBREX 152 145 54 80
LANSOPRAZOLE 147 146 55 113
NAMENDA 143 143 56 47
BUMETANIDE 139 138 57 209
CLONIDINE 139 115 57 295
MECLIZINE HCL 135 135 59 81
ZETIA 135 126 59 68
ADVAIR DISKUS 133 111 61 32
GABAPENTIN 132 131 62 21
SANTYL 131 131 63 124
MELOXICAM 128 108 64 53
SYMBICORT 127 124 65 120
QUETIAPINE FUMARATE 126 110 66 75
NIFEDIPINE ER 122 122 67 48
IBUPROFEN 117 107 68 72
CITALOPRAM HBR 114 84 69 31
DEXILANT 113 113 70 118
CREON 113 105 70 111
ALCOHOL SWABS 112 108 72 115
ESCITALOPRAM OXALATE 112 85 72 89
MIRTAZAPINE 109 97 74 45
AMMONIUM LACTATE 109 104 74 91
PROPRANOLOL HCL 108 108 76 199
SPIRIVA 107 98 77 54
RISPERIDONE 101 100 78 78
QUINAPRIL HCL 99 87 79 82
ALLOPURINOL 96 82 80 41
DOXAZOSIN MESYLATE 95 95 81 103
SERTRALINE HCL 93 91 82 30
SOLARAZE 91 89 83 157
LABETALOL HCL 89 86 84 114
NYSTATIN-TRIAMCINOLONE 89 69 84 142
FLUTICASONE PROPIONATE 89 85 84 38
PROCTOZONE-HC 87 85 87 171
NITROSTAT 86 83 88 205
PAROXETINE HCL 85 73 89 93
CLONIDINE HCL 85 81 89 79
LEVETIRACETAM 83 69 91 92
AGGRENOX 82 66 92 235
AZITHROMYCIN 81 73 93 42
LEXAPRO 81 72 93 193
SEROQUEL 80 77 95 166
SINGULAIR 78 77 96 62
LYRICA 76 76 97 133
MICARDIS 73 73 98 154
CIPROFLOXACIN HCL 71 69 99 84
AMLODIPINE BESYLATE-BENAZEPRIL 70 69 100 55
JANUMET 70 66 100 77
PANTOPRAZOLE SODIUM 69 66 102 61
KLOR-CON 10 67 67 103 225
GLIPIZIDE XL 66 60 104 83
SPIRONOLACTONE 64 53 105 88
NITROGLYCERIN PATCH 64 64 105 149
HUMULIN 70-30 62 61 107 328
DICYCLOMINE HCL 62 61 107 224
RANEXA 61 49 109 167
INSULIN SYRINGE 61 56 109 137
RAMIPRIL 61 55 109 50
BONIVA 60 60 112 236
GLIMEPIRIDE 58 58 113 37
NOVOLIN 70-30 58 55 113 287
CYCLOBENZAPRINE HCL 58 56 R 113 143
OXYCODONE-ACETAMINOPHEN 57 55 S2 116 101
LEVOFLOXACIN 56 48 117 109
CICLOPIROX 56 54 117 279
PRANDIN 54 54 119 150
CLOBETASOL PROPIONATE 54 54 119 130
TRAMADOL HCL 54 54 119 40
LANTUS SOLOSTAR 54 51 119 70
CARBIDOPA-LEVODOPA 52 29 123 98
PREDNISONE 51 47 124 52
ZOVIRAX 50 49 125 313
PRAZOSIN HCL 50 50 125 527
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.